Trials / Completed
CompletedNCT01779258
Emollients in the Management of Atopic Dermatitis
Emollients in the Management of Atopic Dermatitis in Children: Prevention of Flares.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 347 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- All
- Age
- 2 Years – 6 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm that emollients play a major role in the maintenance therapy after clearing of inflammatory lesions and can reduce occurrence of flares in children with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | glycerol, paraffin (liquid and white soft) | 1 application in the morning and in the evening |
| DEVICE | Atopiclair® | 1 application in the morning, in the afternoon and in the evening |
| DRUG | Locatop@ | During the Run-In period: 1 application in the morning and in the evening during a maximum of 21 days |
| DRUG | Locapred@ | During the 3 months study treatment: 1 application in the evening in case of flare " |
Timeline
- Start date
- 2013-02-01
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2013-01-30
- Last updated
- 2014-02-19
Locations
15 sites across 5 countries: Estonia, France, Lithuania, Poland, Romania
Source: ClinicalTrials.gov record NCT01779258. Inclusion in this directory is not an endorsement.